Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Clinical trial NCT01782300 · COMPLETED
Trial details
- NCT number
- NCT01782300
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.